Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Rimonabant is a selective CB1 receptor antagonist approved in Europe for the treatment of obesity. Due to serious psychological side effects such as depression, the substance was withdrawn from the market.
…